VISFO
Knowledge base

Market Access Key Opinion Leaders (MAKOLs)

Refine your stakeholder engagement strategy and leverage Market Access Key Opinion Leader (MAKOL) expertise, influence and networks to drive evidence-based access and reimbursement strategies.
Credit card mockupColorful gradient
Market Access Key Opinion Leaders (MAKOLs)

Definition and criteria

A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:

Criteria 1

Demonstrates a strong publication record in peer-reviewed journals, publishing on themes such as: unmet needs; disease and economic burden; cost-effectiveness and budget impact of current and emerging therapies; healthcare resource utilization; reimbursement and access challenges

Criteria 2

Consistently authors systematic reviews, guidelines, or meta-analyses

Criteria 3

A well-respected researcher, clinician, economist or health policy expert

Criteria 4

Involved in country-specific or regional policy development and health economics initiatives

Criteria 5

Criteria 6

This is some text inside of a div block.

Power your decision-making

with bespoke and intuitive intelligence boards

Visualize

VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.

Identify

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Analyze

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

HelixAI
Market Access Key Opinion Leaders (MAKOLs)

Use cases

How can this help your team...

Medical Affairs

Encourage collaboration between Medical Affairs teams and MAKOLs to facilitate understanding and communication of your therapy’s value to healthcare providers and other stakeholders
Partner with MAKOLs to co-author peer-reviewed publications and participate in advisory boards to highlight emerging trends and therapies
Guide post-approval studies

Market Access

Empower market access teams to create compelling value propositions that align with payer priorities
Develop evidence-based market access and reimbursement strategies
Build awareness of, and support for, your product among key stakeholders

Clinical Development

Identify and target patient subgroups with the highest unmet need
Guide drug development strategies and clinical trial design to incorporate endpoints relevant to market access, such as quality of life, healthcare resource utilization and cost-effectiveness
Define value drivers for your therapeutic area early, to anticipate payer requirements for clinical evidence

Build your solution

Take a guided walkthrough of how we solve complex challenges, step by step. Just tell us what you’re facing, and we’ll show you how data science, expert insight, and software come together to deliver lasting results.
Dashboard mockupiPhone mockup